Rare Disease Oncology Product Strategy Lead (Remote)

Jubilant Pharma Limited; Yardley (Bucks County); Remote; USD 130,000 - 180,000; Full time

Benefits offered by this job

Competitive total compensation

Comprehensive benefits

Opportunities for growth

Job summary

Jubilant Pharma Limited is seeking an Associate Director/Director of Product Management specializing in Oncology (Rare Disease) to lead the development of innovative strategies. This remote/hybrid role focuses on enhancing patient access to life-changing therapies for neuroblastoma. The ideal candidate will have a strong background in pharmaceutical marketing, particularly within rare diseases, and a proven ability to work cross-functionally.

This position offers a unique opportunity to directly impact treatment access and patient outcomes, making a significant difference in the lives of children facing serious conditions.

Qualifications

• 7 to 12+ years of experience in pharmaceutical or biotech marketing.
• Proven experience in rare disease and/or oncology commercialization.
• Ability to operate in ambiguity and build strategy from the ground up.

Responsibilities

• Lead go-to-market strategy for an orphan oncology product.
• Build understanding of patient journey and identify treatment barriers.
• Develop payer value propositions and reimbursement strategies.

Skills

Pharmaceutical or biotech marketing

Rare disease commercialization

Patient journey mapping

Cross-functional collaboration

Payer strategy development

Job description

Jubilant Pharma Limited is seeking an Associate Director/Director of Product Management specializing in Oncology (Rare Disease) to lead the development of innovative strategies. This remote/hybrid role focuses on enhancing patient access to life-changing therapies for neuroblastoma. The ideal candidate will have a strong background in pharmaceutical marketing, particularly within rare diseases, and a proven ability to work cross-functionally.

This position offers a unique opportunity to directly impact treatment access and patient outcomes, making a significant difference in the lives of children facing serious conditions.